FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1979024995> ?p ?o ?g. }

• W1979024995 endingPage "586" @default.
• W1979024995 startingPage "576" @default.
• W1979024995 abstract "CD39 (ecto-nucleoside triphosphate diphosphohydrolase-1; E-NTPDase-1), is highly expressed on quiescent vascular endothelial cells and efficiently hydrolyzes extracellular ATP and ADP to AMP and ultimately adenosine. This action blocks extracellular nucleotide-dependent platelet aggregation and abrogates endothelial cell activation. However, CD39 enzymatic activity is rapidly lost following exposure to oxidant stress. Modulation of extracellular nucleotide levels may therefore play an important role in the pathogenesis of vascular injury. Acute ischemic injury of the bowel is a serious medical condition characterized by high mortality rates with limited therapeutic options. Here we evaluate the effects of cd39-deletion in mutant mice and the use of supplemental NTPDase or adenosine in influencing the outcomes of intestinal ischemia-reperfusion. Wild-type, cd39-null, or hemizygous cd39-deficient mice were subjected to intestinal ischemia. In selected animals, 0.2 U/g apyrase (soluble NTPDase) was administered prior to re-establishment of blood-flow. In parallel experiments adenosine/amrinone was infused over 60 min during reperfusion periods. Survival rates were determined, serum and tissue samples were taken. Intravital videomicroscopy and studies of vascular permeability were used to study platelet-endothelial cell interactions and determine capillary leakage. In wild-type animals, ischemia reperfusion injury resulted in 60% mortality within 48 hours. In mutant mice null or deficient for cd39, ischemia reperfusion-related death occurred in 80% of animals. Apyrase supplementation protected all wild-type animals from death due to intestinal ischemia but did not fully protect cd39-null and cd39-hemizygote mice. Adenosine/amrinone treatment failed to improve survival figures. In wild type mice, platelet adherence to postcapillary venules was significantly decreased and vascular integrity was well preserved following apyrase administration. In cd39-null mice, ischemia-reperfusion induced marked albumin leakage indicative of heightened vascular permaeability when compared to wild-type animals (p=0.04). Treatment with NTPDase or adenosine supplementation abrogated the increased vascular permeability in ischemic jejunal specimens of both wild-type mice and cd39-null. CD39 activity modulates platelet activation and vascular leak during intestinal ischemia reperfusion injury in vivo. The potential of NTPDases to maintain vascular integrity suggests potential pharmacological benefit of these agents in mesenteric ischemic injury." @default.
• W1979024995 created "2016-06-24" @default.
• W1979024995 creator A5012615383 @default.
• W1979024995 creator A5019777904 @default.
• W1979024995 creator A5022448257 @default.
• W1979024995 creator A5033779581 @default.
• W1979024995 creator A5041621533 @default.
• W1979024995 creator A5050854410 @default.
• W1979024995 creator A5055619602 @default.
• W1979024995 creator A5060663408 @default.
• W1979024995 date "2004-01-01" @default.
• W1979024995 modified "2023-10-18" @default.
• W1979024995 title "Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury" @default.
• W1979024995 cites W1522010565 @default.
• W1979024995 cites W1565285014 @default.
• W1979024995 cites W159822751 @default.
• W1979024995 cites W169645809 @default.
• W1979024995 cites W1815757713 @default.
• W1979024995 cites W1897717892 @default.
• W1979024995 cites W1955338813 @default.
• W1979024995 cites W1965349478 @default.
• W1979024995 cites W1970664371 @default.
• W1979024995 cites W1983995935 @default.
• W1979024995 cites W1984168995 @default.
• W1979024995 cites W1992942911 @default.
• W1979024995 cites W2044014719 @default.
• W1979024995 cites W2050430854 @default.
• W1979024995 cites W2058768349 @default.
• W1979024995 cites W2059829735 @default.
• W1979024995 cites W2063215305 @default.
• W1979024995 cites W2071032140 @default.
• W1979024995 cites W2076034180 @default.
• W1979024995 cites W2105855967 @default.
• W1979024995 cites W2105868915 @default.
• W1979024995 cites W2107440856 @default.
• W1979024995 cites W2116238347 @default.
• W1979024995 cites W2116638383 @default.
• W1979024995 cites W2117204128 @default.
• W1979024995 cites W2117926778 @default.
• W1979024995 cites W2128635872 @default.
• W1979024995 cites W2133203059 @default.
• W1979024995 cites W2133348699 @default.
• W1979024995 cites W2159022158 @default.
• W1979024995 cites W2171678969 @default.
• W1979024995 cites W2200842953 @default.
• W1979024995 cites W2327778167 @default.
• W1979024995 cites W2341557366 @default.
• W1979024995 cites W2402835926 @default.
• W1979024995 cites W2409772411 @default.
• W1979024995 cites W2414792168 @default.
• W1979024995 cites W2414813949 @default.
• W1979024995 cites W77788505 @default.
• W1979024995 doi "https://doi.org/10.1160/th03-06-0373" @default.
• W1979024995 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14983235" @default.
• W1979024995 hasPublicationYear "2004" @default.
• W1979024995 type Work @default.
• W1979024995 sameAs 1979024995 @default.
• W1979024995 citedByCount "74" @default.
• W1979024995 countsByYear W19790249952012 @default.
• W1979024995 countsByYear W19790249952013 @default.
• W1979024995 countsByYear W19790249952014 @default.
• W1979024995 countsByYear W19790249952015 @default.
• W1979024995 countsByYear W19790249952016 @default.
• W1979024995 countsByYear W19790249952017 @default.
• W1979024995 countsByYear W19790249952018 @default.
• W1979024995 countsByYear W19790249952020 @default.
• W1979024995 countsByYear W19790249952021 @default.
• W1979024995 countsByYear W19790249952023 @default.
• W1979024995 crossrefType "journal-article" @default.
• W1979024995 hasAuthorship W1979024995A5012615383 @default.
• W1979024995 hasAuthorship W1979024995A5019777904 @default.
• W1979024995 hasAuthorship W1979024995A5022448257 @default.
• W1979024995 hasAuthorship W1979024995A5033779581 @default.
• W1979024995 hasAuthorship W1979024995A5041621533 @default.
• W1979024995 hasAuthorship W1979024995A5050854410 @default.
• W1979024995 hasAuthorship W1979024995A5055619602 @default.
• W1979024995 hasAuthorship W1979024995A5060663408 @default.
• W1979024995 hasConcept C104317684 @default.
• W1979024995 hasConcept C126322002 @default.
• W1979024995 hasConcept C134018914 @default.
• W1979024995 hasConcept C18880352 @default.
• W1979024995 hasConcept C203014093 @default.
• W1979024995 hasConcept C2776991684 @default.
• W1979024995 hasConcept C2779508331 @default.
• W1979024995 hasConcept C2780114680 @default.
• W1979024995 hasConcept C28406088 @default.
• W1979024995 hasConcept C2994266630 @default.
• W1979024995 hasConcept C512185932 @default.
• W1979024995 hasConcept C541997718 @default.
• W1979024995 hasConcept C55493867 @default.
• W1979024995 hasConcept C71924100 @default.
• W1979024995 hasConcept C86803240 @default.
• W1979024995 hasConcept C89560881 @default.
• W1979024995 hasConcept C98274493 @default.
• W1979024995 hasConceptScore W1979024995C104317684 @default.
• W1979024995 hasConceptScore W1979024995C126322002 @default.
• W1979024995 hasConceptScore W1979024995C134018914 @default.
• W1979024995 hasConceptScore W1979024995C18880352 @default.

• next